花生四烯乙醇胺

(重定向自花生四烯酸乙醇胺

花生四烯乙醇胺,又名N-花生四烯乙醇胺AEA,是一種內源性的大麻醇類神經傳導物質。命名取自梵文(和印度半島宗教用語)中的「阿難陀(ananda)」,意为“喜悅、極樂、欣喜”,以及醯胺[3][4]。它是由N-花生四烯酰磷脂酰乙醇胺透過多種途徑合成[5]。花生四烯乙醇胺,主要是由脂肪酸醯胺水解酶(FAAH)將其降解乙醇胺花生四烯酸。如此,脂肪酸醯胺水解酶(FAAH)的抑制物導致花生四烯乙醇胺層級的提升,並被用于治療[6][7]

花生四烯乙醇胺
IUPAC名
(5Z,8Z,11Z,14Z)-N-(2-hydroxyethyl)icosa-5,8,11,14-tetraenamide
别名 N-arachidonoylethanolamine
花生四烯酰乙醇胺[1]
花生四烯酸乙醇胺[2]
识别
CAS号 94421-68-8  checkY
PubChem 5281969
ChemSpider 4445241
SMILES
 
  • O=C(NCCO)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC
InChI
 
  • 1/C22H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-22(25)23-20-21-24/h6-7,9-10,12-13,15-16,24H,2-5,8,11,14,17-21H2,1H3,(H,23,25)/b7-6-,10-9-,13-12-,16-15-
InChIKey LGEQQWMQCRIYKG-DOFZRALJBA
ChEBI 2700
MeSH Anandamide
IUPHAR配体 2364
性质
化学式 C22H37NO2
摩尔质量 347.53 g/mol g·mol⁻¹
若非注明,所有数据均出自标准状态(25 ℃,100 kPa)下。

歷史

花生四烯乙醇胺的結構最初由W. A. Devane, Lumír Hanuš等人在1992年時提到。當時他們在耶路撒冷希伯來大學一個由Raphael Mechoulam帶領的團隊工作。[8]

生理功能

花生四烯乙醇胺可以作用在人體的中樞神經系統 ,例如腦部周圍以及身體的其他部位。這些作用主要是由在中樞神經系統中的CB1大麻素受體,以及在周圍神經系統的CB2大麻素受體調節。[9]後者主要參與免疫系統的功能作用。大麻素受體最初被發現時,其被發現對Δ9四氫大麻酚(Δ9-THC,通常稱為THC)較為敏感,而其也正是大麻中的主要精神活性物質。而大麻素也因其對CB1和CB2受體不可避免的的影響而被發現。

花生四烯乙醇胺已經被證實會影響實驗鼠的工作記憶。[10]而現在的研究正在探討大麻素作用對人類行為的影響,例如:在進食和睡眠的模式,以及疼痛減輕。花生四烯乙醇胺也對早期胚胎胚囊著床在子宮時有重要影響。因此大麻素,例如:Δ9-THC,可能在人妊娠的早期階段影響其過程。[11]花生四烯乙醇胺在血漿中的高峰期一般發生在排卵期,並與雌二醇促性腺激素呈現正相關,這表明了以上這些物質可能參與了對花生四烯乙醇胺的調節。[12]而後,花生四烯乙醇胺曾被提議用來作為不孕症的生物標誌物,但迄今為止在臨床上尚無任何預測值。[13]

花生四烯乙醇胺在攝食行為中扮演著調節的角色,而神經作用的行為以及產生愉悅的感受也受其影響。此外,將花生四烯乙醇胺直接注入大鼠的前腦正向強化刺激相關區域伏隔核時,會增強大鼠對於所攝取蔗糖的愉悅感,並且會增進食物的攝入量。

在一項研究中,運動的急性有益效果似乎在實驗鼠中也由花生四烯乙醇胺調節。[14]花生四烯乙醇胺也是一類酰胺前體的生理活性物質的先驅。

在1998年發表的一篇研究中也曾經提到花生四烯乙醇抑制某些人類乳腺癌細胞系的增殖。[15]該現象隨後在2007年的另一項研究中被再次證實。[16]

在1996年,研究人員發現巧克力中含有花生四烯乙醇胺。他們也發現,有兩種物質(N-oleoylethanolamine 和 N-linoleoylethanolamine)會模仿花生四烯乙醇胺帶來的影響。[17]

合成與降解

人體可以由N-花生四烯酰磷脂酰乙醇胺(NAPE)合成花生四烯乙醇胺,而N-花生四烯酰磷脂酰乙醇胺(NAPE)本身是透過N-酰基轉移酶,將花生四烯酸從卵磷脂轉移至腦磷脂上的游離胺上。[18][19] 花生四烯乙醇胺由NAPE的合成可以透過多種途徑達成,包括酵素的參與,例如磷脂酶A2、磷脂酶C和NAPE-PLD[5]。 內源性花生四烯乙醇胺並不常存在且其半生期非常短,因為脂肪酸酰胺水解酶(FAAH)的作用,會將其分解成游離的花生四烯酸和乙醇胺。與仔豬相關的研究表明,花生四烯酸及其它必需脂肪酸的攝入量會影響其腦部花生四烯乙醇胺和其他內源性大麻素的量[20]。而被以高脂肪飲食飼養的小鼠,其肝臟中的花生四烯乙醇胺的量會增加,同時也會增進脂肪的生成[21]。這說明了至少在齧齒動物中,花生四烯乙醇胺對於肥胖的發展會產生影響。 對乙酰氨基酚(acetaminophen)在代謝上,會透過FAAH,去和花生四烯酸結合而形成AM404[22]。此對乙酰氨基酚(acetaminophen)的代謝產物,對於TRPV1香草素受體,是一種強促效劑,但對於CB1和CB2受體,為弱促效劑,而對於花生四烯乙醇胺而言,為再吸收抑制劑。因此,身體和大腦中花生四烯乙醇胺的量提升。以此方式,對乙酰氨基酚(acetaminophen)可作為仿大麻素代謝產物的前體藥物。這個作用可以使得對乙酰氨基酚(acetaminophen)的鎮痛作用受到部分或全部的影響[23][24] 。花生四烯乙醇胺和其姊妹分子2-花生四烯酸甘油酯的運輸蛋白已經被鑑定確認了,包括熱休克蛋白(Hsp70s)和脂肪酸結合蛋白(FABPs)。[25][26]

药用价值

英國皇家化學學會曾表示,有研究顯示AM1172有可能被開發成藥物,可以提升大腦的花生四烯乙醇胺含量,因而能够用來治療焦慮以及憂鬱。[27]

参见

參考文獻

  1. ^ 唐双奇; 陆阳. 内源性大麻素—生物合成、信号转导及生物降解. 中国药理学通报. 2013, 29 (08): 1037–1041. 
  2. ^ 封玉玲; 陈杰; 封海涛; 董志; 李晶. 脑脊液中花生四烯酸乙醇胺浓度变化与精神分裂症的病理机制. 中国医院药学杂志. 2014, 34 (01): 8–11. doi:10.13286/j.cnki.chinhosppharmacyj.2014.01.03. 
  3. ^ Devane, W.; Hanus, L; Breuer, A; Pertwee, R.; Stevenson, L.; Griffin, G; Gibson, D; Mandelbaum, A; Etinger, A; Mechoulam, R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 18 December 1992, 258 (5090): 1946–1949. doi:10.1126/science.1470919. 
  4. ^ Mechoulam R, Fride E. The unpaved road to the endogenous brain cannabinoid ligands, the anandamides. Pertwee RG (编). Cannabinoid receptors. Boston: Academic Press. 1995: 233–258. ISBN 0-12-551460-3. 
  5. ^ 5.0 5.1 Wang, Jun; Ueda, Natsuo. Biology of endocannabinoid synthesis system. Prostaglandins & Other Lipid Mediators (Elsevier BV). 2009, 89 (3-4): 112–119. ISSN 1098-8823. doi:10.1016/j.prostaglandins.2008.12.002. 
  6. ^ Gaetani, Silvana; Dipasquale, Pasqua; Romano, Adele; Righetti, Laura; Cassano, Tommaso; Piomelli, Daniele; Cuomo, Vincenzo. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.. International review of neurobiology. 2009, 85: 57–72. PMID 19607961. doi:10.1016/S0074-7742(09)85005-8. 
  7. ^ Hwang, Jeannie; Adamson, Crista; Butler, David; Janero, David R.; Makriyannis, Alexandros; Bahr, Ben A. Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: A neuroprotective therapeutic modality. Life Sciences. April 2010, 86 (15-16): 615–623. doi:10.1016/j.lfs.2009.06.003. 
  8. ^ Mechoulam, WA; Hanus L; Breuer A; Pertwee RG; Stevenson LA; Griffin G; Gibson D; Mandelbaum A; Etinger A; Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. December 1992, 258 (5090): 1946–9 [2015-01-18]. Bibcode:1992Sci...258.1946D. PMID 1470919. doi:10.1126/science.1470919. (原始内容存档于2014-08-10). 
  9. ^ Pacher, P. The Endocannabinoid System as an Emerging Target of Pharmacotherapy. Pharmacological Reviews (American Society for Pharmacology & Experimental Therapeutics (ASPET)). 2006-09-01, 58 (3): 389–462. ISSN 0031-6997. doi:10.1124/pr.58.3.2. 
  10. ^ allet PE, Beninger RJ; Beninger. The endogenous cannabinoid receptor agonist anandamide impairs memory in rats. Behavioural Pharmacology. 1996, 7 (3): 276–284 [2015-01-18]. doi:10.1097/00008877-199605000-00008. (原始内容存档于2019-12-09). 
  11. ^ Piomelli D. THC: moderation during implantation. Nat. Med. January 2004, 10 (1): 19–20. PMID 14702623. doi:10.1038/nm0104-19. 
  12. ^ El-Talatini MR, Taylor AH, Konje JC; Taylor; Konje. The relationship between plasma levels of the endocannabinoid, anandamide, sex steroids, and gonadotrophins during the menstrual cycle. Fertil. Steril. April 2010, 93 (6): 1989–96. PMID 19200965. doi:10.1016/j.fertnstert.2008.12.033. 
  13. ^ Rapino, C.; Battista, N.; Bari, M.; Maccarrone, M. Endocannabinoids as biomarkers of human reproduction. Human Reproduction Update. 2014, 20 (4): 501–516. ISSN 1355-4786. PMID 24516083. doi:10.1093/humupd/dmu004. 
  14. ^ Fuss, Johannes; Steinle, Jörg; Bindila, Laura; Auer, Matthias K.; Kirchherr, Hartmut; Lutz, Beat; Gass, Peter. A runner’s high depends on cannabinoid receptors in mice. Proceedings of the National Academy of Sciences. 2015-10-20, 112 (42) [2024-01-26]. ISSN 0027-8424. doi:10.1073/pnas.1514996112. (原始内容存档于2023-02-19) (英语). 
  15. ^ De Petrocellis, Luciano; Melck, Dominique; Palmisano, Antonella; Bisogno, Tiziana; Laezza, Chiara; Bifulco, Maurizio; Di Marzo, Vincenzo. The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proceedings of the National Academy of Sciences. 7 July 1998, 95 (14): 8375–8380. PMID 9653194. doi:10.1073/pnas.95.14.8375. 
  16. ^ De Petrocellis, Luciano; Melck, Dominique; Palmisano, Antonella; Bisogno, Tiziana; Laezza, Chiara; Bifulco, Maurizio; Di Marzo, Vincenzo. The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proceedings of the National Academy of Sciences. 1998-07-07, 95 (14) [2024-01-26]. ISSN 0027-8424. doi:10.1073/pnas.95.14.8375. (原始内容存档于2024-01-26) (英语). 
  17. ^ di Tomaso E, Beltramo M, Piomelli D.; Beltramo; Piomelli. Brain cannabinoids in chocolate. Nature. Aug 1996, 382 (6593): 677–8. PMID 8751435. doi:10.1038/382677a0. 
  18. ^ Natarajan V, Reddy PV, Schmid PC, Schmid HH; Reddy; Schmid; Schmid. N-Acylation of ethanolamine phospholipids in canine myocardium. Biochim. Biophys. Acta. August 1982, 712 (2): 342–55. PMID 7126608. doi:10.1016/0005-2760(82)90352-6. 
  19. ^ Cadas H, di Tomaso E, Piomelli D; Di Tomaso; Piomelli. Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain. J. Neurosci. February 1997, 17 (4): 1226–42. PMID 9006968. 
  20. ^ Berger, Alvin; Crozier, Gayle; Bisogno, Tiziana; Cavaliere, Paolo; Innis, Sheila; Di Marzo, Vincenzo. Anandamide and diet: Inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets. Proceedings of the National Academy of Sciences. 15 May 2001, 98 (11): 6402–6406. PMID 11353819. doi:10.1073/pnas.101119098. 
  21. ^ Osei-Hyiaman, Douglas; DePetrillo, Michael; Pacher, Pál; Liu, Jie; Radaeva, Svetlana; Bátkai, Sándor; Harvey-White, Judith; Mackie, Ken; Offertáler, László; Wang, Lei; Kunos, George. Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. Journal of Clinical Investigation. 2 May 2005, 115 (5): 1298–1305. PMID 15864349. doi:10.1172/JCI23057. 
  22. ^ Högestätt, Edward D.; Jönsson, Bo A. G.; Ermund, Anna; Andersson, David A.; Björk, Henrik; Alexander, Jessica P.; Cravatt, Benjamin F.; Basbaum, Allan I.; Zygmunt, Peter M. Conversion of Acetaminophen to the BioactiveN-Acylphenolamine AM404 via Fatty Acid Amide Hydrolase-dependent Arachidonic Acid Conjugation in the Nervous System. Journal of Biological Chemistry (American Society for Biochemistry & Molecular Biology (ASBMB)). 2005-06-29, 280 (36): 31405–31412. ISSN 0021-9258. doi:10.1074/jbc.m501489200. 
  23. ^ Bertolini, Alfio; Ferrari, Anna; Ottani, Alessandra; Guerzoni, Simona; Tacchi, Raffaella; Leone, Sheila. Paracetamol: New Vistas of an Old Drug. CNS Drug Reviews. September 2006, 12 (3-4): 250–275. PMID 17227290. doi:10.1111/j.1527-3458.2006.00250.x. 
  24. ^ Sinning, Christian; Watzer, Bernhard; Coste, Ovidiu; Nüsing, Rolf M.; Ott, Ingo; Ligresti, Alessia; Marzo, Vincenzo Di; Imming, Peter. New Analgesics Synthetically Derived from the Paracetamol Metabolite-(4-Hydroxyphenyl)-(5,8,11,14)-icosatetra-5,8,11,14-enamide. Journal of Medicinal Chemistry. 25 December 2008, 51 (24): 7800–7805. PMID 19053765. doi:10.1021/jm800807k. 
  25. ^ Kaczocha, M.; Glaser, S.T.; Deutsch, D.G. Identification of intracellular carriers for the endocannabinoid anandamide. Proceedings of the National Academy of Sciences of the United States of America. 2009, 106 (15): 6375–6380. PMC 2669397 . PMID 19307565. doi:10.1073/pnas.0901515106. 
  26. ^ Oddi, S.; Fezza, F.; Pasquariello, N.; D'Agostino, A.; Catanzaro, G.; De Simone, C.; Rapino, C.; Finazzi-Agro, A.; Maccarrone, M. Molecular identification of albumin and Hsp70 as cytosolic anandamide-binding proteins. Chemistry & Biology. 2009, 16 (6): 624–632. PMID 19481477. doi:10.1016/j.chembiol.2009.05.004. 
  27. ^ Evans, Jon. Easing anxiety with anandamide. Chemistry World. July 2004 [2015-01-18]. (原始内容存档于2014-12-24). 

外部連結